Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
19.05.Ionis chalks up phase 3 trial win as it works to grow the reach of Tryngolza
19.05.Former President Joe Biden diagnosed with 'aggressive' prostate cancer
19.05.Regeneron's $256M bid wins 23andMe bankruptcy auction
19.05.Amid US investment push, Lilly eyes Houston as potential home for $5.9B API plant
19.05.After FDA holdup, Novavax secures full approval for protein-based COVID vaccine
16.05.Weighing approval bids from J&J, Pfizer and Roche, FDA scrutinizes data ahead of adcomm
16.05.HHS, DARPA link up with Rutgers, Cost Plus Drugs and others in initiative to rethink US drug production
16.05.After 19 months, FDA lifts clinical hold on vaginal yeast infection drug Brexafemme
16.05.With marketing chief's departure, Omnicom Health loses another exec ahead of Interpublic merger
16.05.WuXi Biologics slims down again, handing off German plant to CDMO Terumo for $167M
16.05.Incyte's Zynyz secures approvals in anal cancer 4 years after FDA rejection
16.05.Novo to part ways with longtime CEO Lars Fruergaard Joergensen, citing weight of market pressures
15.05.Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
15.05.GSK sponsors Lifetime movie for meningitis B vaccine awareness, with help from 'Buffy' stars
15.05.Merck KGaA cites Trump tariffs, funding cuts as it scales back 2025 contracting forecast
15.05.Novartis, Sarepta tipped to drive genomic therapy sales toward $90B
15.05.Riding its Peloton buyout, Merck rolls to third FDA nod for potential blockbuster Welireg
15.05.Merck's Keytruda finds a path in ovarian cancer with phase 3 win in certain patients
14.05.AbbVie advances solid tumor agenda with FDA nod for lung cancer ADC Emrelis
14.05.Sanofi hops on the US investment bandwagon with $20B commitment through 2030
14.05.Genentech pays tribute to moms of children with hemophilia A in Hemlibra short film
14.05.Roche to reconsider US investment projects if Trump follows through on pricing order
14.05.Apellis' weak quarter for Syfovre signals uphill climb for geographic atrophy med: analyst
14.05.AbbVie plant workers in Ireland threaten to strike over pay dispute: reports
14.05.Bluebird bio investor reluctance pays off as Carlyle, SK improve buyout offer by 67%